Antiandrogen Withdrawal Syndrome Associated with Prostate Cancer Therapies: Incidence and Clinical Significance

ISSN： 0114-5916

Source： Drug Safety, Vol.23, Iss.5, 2000-11, pp. : 381-390

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted therapies for prostate cancer

By Asatiani Ekatherine Gelmann Edward P

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 2, 2005-04 ,pp. : 283-298

Informa Healthcare

Access to resources Recommend Favorite

Combination Therapy of Antiandrogen and XIAP Inhibitor for Treating Advanced Prostate Cancer

By Danquah Michael

Pharmaceutical Research, Vol. 29, Iss. 8, 2012-08 ,pp. : 2079-2091

Springer Publishing Company

Access to resources Recommend Favorite

Quo vadis: Advanced prostate cancer—clinical care and clinical research in the era of multiple androgen receptor-directed therapies

By Kim Won Ryan Charles J.

Cancer, Vol. 121, Iss. 3, 2015-02 ,pp. : 361-371

Blackwell Publishing

Access to resources Recommend Favorite

Prostate Cancer: Incidence, Management and Outcomes

By Small E.J.

Drugs & Aging, Vol. 13, Iss. 1, 1998-07 ,pp. : 71-81

Adis International

Access to resources Recommend Favorite

Abdominal Aortic Calcification: Clinical Significance, Mechanisms and Therapies

Current Pharmaceutical Design, Vol. 20, Iss. 37, 2014-01 ,pp. : 5834-5838

Bentham Science Publishers

Access to resources Recommend Favorite